君实生物(01877)今日盘中大涨5.03%,引发市场关注。综合分析来看,公司本次股价大涨或主要受三季报佳绩以及核心产品销售表现向好等因素影响。
数据显示,君实生物三季度实现营收12.71亿元人民币,同比增长28.87%。其中,核心产品特瑞普利单抗在全球30多个国家和地区的销售收入同比增长约60%,达到10.68亿元。
虽然公司仍处于亏损状态,但亏损幅度较上年同期有所收窄,反映公司业务发展向好,商业化进程取得显著进展。公司前景向好助推投资者信心,或是该股今日大涨的主要推手。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.